This study is looking at whether using a CPAP (Continuous Positive Airway Pressure) machine can help reduce atrial fibrillation (AFib) in people who also have moderate to severe obstructive sleep apnea (OSA). You might be able to join if you are 18-85 years old, have AFib that occurs often, and have moderate to severe OSA. You also need to have an implanted heart device that monitors your heart rhythm and be enrolled in remote monitoring. The study will measure the change in how much AFib you experience over about 13 weeks. The current recruitment status is unclear.

Study design

This is a pilot N-of-1 randomized crossover study, meaning each of the 20 participants will try both CPAP and no CPAP at different times. It is designed to help plan a larger study.

What's involved

You would use CPAP for 2 weeks, then stop for 2 weeks, repeating this cycle for a total of 12 weeks. Your AFib episodes will be tracked by your implanted device, and you will complete a questionnaire about your quality of life.

Compensation

Not stated in the trial record.

Follow-up

Your participation will last up to 13 weeks, which is the duration of the study's primary endpoint measurement.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.